Janssen Launches Health Equity Campaign in Partnership with Award-Winning Radio Host D.L. Hughley to Raise Awareness About Multiple Myeloma Among Black Communities

HORSHAM, P.A., March 2, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the launch of That’s My Word™ to raise awareness of and help to drive better health outcomes for multiple myeloma among at-risk populations. A national campaign bringing together trusted voices among Black communities, including those at risk of multiple myeloma, care partners, healthcare professionals, advocacy groups and award-winning radio host and comedian D.L. Hughley, That’s My Word™ aims to be a source of both information and hope by sharing resources specifically for Black patients and their care partners about this rare blood cancer.Delays in diagnosis and treatment initiation, as well as unequal access to newer and more advanced medicines, are part of the challenging reality that creates significant health disparities in multiple myeloma.[1]Each year, approximately 35,000 people are diagnosed with multiple myeloma in the United States, and more than 20 percent of all cases occur in Black people, with cases on the rise.[2],[3]Multiple myeloma is often diagnosed in people over the age of 60 years, but Black people are typically diagnosed 5-10 years earlier..[2],[4]While Black patients are less likely to have more aggressive disease, they are twice as likely to die from multiple myeloma because it is often undetected until it has progressed to more advanced stages.[1],[3]Yet, studies show that with early diagnosis, early treatment initiation, and equal...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Latest News Source Type: news